Skip to main content
. 2020 Oct 6;22:229. doi: 10.1186/s13075-020-02322-9

Table 3.

Changes of finger JSD of MCP (from thumb to little finger) based on DAS28 remission for RA patients treated with CZP 400 mg plus MTX (*P < 0.01; **P = n. s)

Finger joint space distance Baseline
mean (SD)
in mm
Week 52
mean (SD)
in mm
Difference
DAS28 ≤ 2.6 JSD-MCPthumb 0.147 ± 0.044 0.147 ± 0.051 0%**
JSD-MCPindex finger 0.160 ± 0.060 0.169 ± 0.055 + 5.6%*
JSD-MCPmiddle finger 0.157 ± 0.038 0.162 ± 0.038 + 3.2%*
JSD-MCPring finger 0.153 ± 0.024 0.156 ± 0.022 + 2.0%*
JSD-MCPlittle 0.142 ± 0.031 0.148 ± 0.033 + 4.2%*
JSD-MCPtotal 0.152 ± 0.033 0.157 ± 0.034 + 3.3%*
DAS28 > 2.6 JSD-MCPthumb 0.147 ± 0.042 0.146 ± 0.043 − 0.7%**
JSD-MCPindex finger 0.149 ± 0.061 0.147 ± 0.063 − 1.3%**
JSD-MCPmiddle finger 0.139 ± 0.049 0.139 ± 0.054 0%**
JSD-MCPring finger 0.147 ± 0.036 0.148 ± 0.038 + 0.7%**
JSD-MCPlittle 0.142 ± 0.033 0.142 ± 0.039 0%**
JSD-MCPtotal 0.145 ± 0.034 0.144 ± 0.036 − 0.7%**